NSEGeneral Updates29 Jul 2026 · 29 Jul 2026, 05:50 pm

General Updates

Ind-Swift Laboratories Limited · INDSWFTLAB

✦ AI SummaryResults

Ind-Swift Laboratories Limited has informed about the outcome of the Preferential Issue Committee of the Board of Directors, which considered and approved the Corrigendum to the EGM Notice dated July 29, 2026, convening the Extraordinary General Meeting of the Company scheduled to be held on August 05, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Outcome of the Preferential Issue Committee of the Board of Directors of Ind-Swift Laboratories Limited in terms of the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Attachments (1)

📄

INDSWFTLAB_29072026175028_Committee_Meeting_Outcome_29072026.pdf

pdf

Download →
View document text
Date: July 29, 2026 To, To, Corporate Relationship Department Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, 5th Floor, Plot No. C/2, 25th Floor, Dalal Street, G-Block, Bandra Kurla Complex, Bandra (E), Mumbai – 400001, India Mumbai – 400051, India Scrip Code: 532305 Symbol: INDSWFTLAB Ref.: Outcome of the meeting of Board of Directors held on July 10, 2026. Subject: Outcome of the Preferential Issue Committee of the Board of Directors of Ind-Swift Laboratories Limited in terms of the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Ma’am, With reference to the outcome of the meeting of Board of Directors dated July 10, 2026, and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Preferential Issue Committee of the Board of Directors (“Committee”) of Ind-Swift Laboratories Limited (“the Company”) at its meeting held today i.e. Wednesday, July 29, 2026, inter alia, considered and approved the Corrigendum to the EGM Notice dated July 29, 2026 convening the Extraordinary General Meeting (“EGM”) of the Company scheduled to be held on Wednesday, August 05, 2026, at 11:30 A.M. (IST) through Video Conferencing (“VC”)/Other Audio-Visual Means (“OAVM”), issued for seeking approval of the members, inter alia, for the proposed Preferential Issue of Fully Convertible Warrants. The Committee noted that pursuant to the query letter received from the National Stock Exchange of India Limited dated July 20, 2026, and BSE Limited dated July 22, 2026 (“Stock Exchanges”), certain modifications are required in the Explanatory Statement as set out in Item No. 1 of the said EGM Notice, accordingly, the Committee approved the Corrigendum to the Notice of EGM incorporating the required changes and authorized its circulation to the members of the Company and submission to the Stock Exchanges. The Committee further noted that except for the modifications specifically mentioned in the Corrigendum dated July 29, 2026, all other contents, terms and conditions of the Notice of EGM shall remain unchanged and shall continue to be valid. The Meeting commenced at 04:45 P.M. and concluded at 05:15 P.M. Kindly take the above on record. For Ind-Swift Laboratories Limited Pardeep Verma VP - Corporate Affairs & Company Secretary